Vetticaden Santosh 4
4 · ADVENTRX PHARMACEUTICALS INC · Filed Sep 5, 2012
Insider Transaction Report
Form 4
Vetticaden Santosh
Chief Medical Officer & SVP
Transactions
- Award
Employee Stock Option (Right to Buy)
2012-09-05+600,000→ 600,000 totalExercise: $0.69Exp: 2022-09-05→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to 1/4th of the total number of shares subject to this option on September 5, 2013 and as to 1/48th of the total number of shares subject to this option monthly thereafter for the 36 months following September 2013, subject to the reporting person's continued service with the issuer.